PTCT · ISSUER CIK 1070081
PTC THERAPEUTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 4 PTC THERAPEUTICS, INC. insiders reported $0.00 of open-market purchases and $8.5M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 11 of 11 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$8.5MInsider selling
−$8.5MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202617:20 | Oct 14, 2026 | PTCT | Director | S · Sell10b5-1 | $59.61 | −2,500 | 1,291,594 | -0% | −$149K | ||
| Oct 13, 202617:20 | Oct 9, 2026 | PTCT | EXEC. VP AND CLO | S · Sell10b5-1 | $64.26 | −192 | 105,272 | -0% | −$12K | ||
| Oct 13, 202617:20 | Oct 9, 2026 | PTCT | EXEC. VP AND CLO | M · Exercise10b5-1 | $39.42 | +192 | 105,464 | +0% | $8K | ||
| Oct 9, 202617:20 | Oct 7, 2026 | PTCT | Director | S · Sell10b5-1 | $63.39 | −2,500 | 1,294,094 | -0% | −$158K | ||
| Oct 7, 202617:20 | Oct 6, 2026from Oct 5, 2026 | PTCT | EXEC. VP AND CLO | S · Sell10b5-1 | $64.06 | −2,073 | 105,272 | -2% | −$133K | ||
| Oct 7, 202617:20 | Oct 6, 2026from Oct 5, 2026 | PTCT | EXEC. VP AND CLO | M · Exercise10b5-1 | $39.42 | +2,073 | 105,707 | +2% | $82K | ||
| Oct 2, 202617:20 | Sep 30, 2026 | PTCT | Director | S · Sell10b5-1 | $65.16 | −12,000 | 22,500 | -35% | −$782K | ||
| Oct 2, 202617:20 | Sep 30, 2026 | PTCT | Director | M · Exercise10b5-1 | $11.23 | +12,000 | 34,500 | +53% | $135K | ||
| Sep 18, 202617:20 | Sep 17, 2026from Sep 16, 2026 | PTCT | Director | S · Sell10b5-1 | $67.49 | −20,000 | 1,296,594 | -2% | −$1.3M | ||
| Sep 11, 202617:20 | Sep 10, 2026from Sep 9, 2026 | PTCT | Director | S · Sell10b5-1 | $67.59 | −20,000 | 1,316,594 | -1% | −$1.4M | ||
| Aug 28, 202617:20 | Aug 27, 2026from Aug 26, 2026 | PTCT | Director | S · Sell10b5-1 | $72.26 | −25,000 | 1,336,594 | -2% | −$1.8M | ||
| Aug 21, 202617:20 | Aug 20, 2026from Aug 19, 2026 | PTCT | Director | S · Sell10b5-1 | $72.22 | −25,000 | 1,361,594 | -2% | −$1.8M | ||
| Aug 19, 202617:20 | Aug 17, 2026 | PTCT | EXEC. VP AND CLO | S · Sell10b5-1 | $72.57 | −2,813 | 105,272 | -3% | −$204K | ||
| Aug 19, 202617:20 | Aug 17, 2026 | PTCT | EXEC. VP AND CLO | M · Exercise10b5-1 | $25.69 | +2,813 | 108,085 | +3% | $72K | ||
| Aug 6, 202617:20 | Aug 4, 2026 | PTCT | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $68.57 | −10,292 | 383,868 | -3% | −$706K |